Skin Carcinoma — Trials

Skin Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

389 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 127
Recruiting: 69
Ph III recruiting: 8
Growth YoY: +12%
Industry share: 20%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (52)

clinicaltrialsPublishedShowing 151–153 of 153 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05794035	Impact of Hypofractionated Radiotherapy Strategy After Surgery of Skin Carcinomas in Older Patients(IMPACTE-01)	recruiting	N/A	303	Assistance Publique - Hôpitaux de ParisOTHER	1	Nov 30, 2023	clinicaltrials
NCT05025813	Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma(DESQUAMATE)	recruiting	Phase 2	27	Queensland HealthOTHER_GOV	1	Aug 1, 2022